Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial

NCT00434668 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT00434668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00434668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
November 30, 2010
Enrollment
99 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer